Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic

Clinical trial NCT04769297 · UNKNOWN

Trial details

NCT number: NCT04769297
Sponsor: Limbic Medical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Stress Disorder

Start date: 2020-04-15
Primary completion: 2021-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.